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Many terminally ill patients suffer because of poorly controlled musculoskeletal pain. Oral and parenteral
systemic analgesics are usually ineffective in this type of pain. It is therefore important to diagnose and treat
accordingly. Patients with shoulder pain may suffer from suprascapular nerve entrapment, a syndrome
known from sport and occupational medicine. Within, we describe this syndrome, mechanism of onset,
diagnosis and treatment. Simple injection of local anaesthetics and corticosteroids may have an effect for
several weeks.
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Introduction
Musculoskeletal pain is common in end stages
of many chronic diseases. Long periods of immobil-
ity, poor nutrition and cachexia are known causes of
these complaints. However not many clinicians real-
ize that part of these pain symptoms can be due to
nerve entrapment. Factors that contribute to poorly
understood musculoskeletal pain are: weak mus-
cles, loss of subcutaneous fat tissue, increased joint
mobility and compression against bony edges. This
pain is not only difficult to diagnose but also diffi-
cult to treat with conventional oral and parenteraal
(co-)analgesics.
In this article we describe one of the common
musculoskeletal pain syndromes which depends on
the traction of the suprascapular nerve. After con-
sidering its anatomy and physiology we shall ex-
plain the mechanism of the onset of pain and using
this knowledge, propose treatment.
Functional anatomy
The shoulder blade (scapula) is an important bone
in the shoulder girdle. It connects the shoulder with
chest and accommodates the shoulder movement.
The triangle-shaped shoulder blade is on one side
connected by joints with the humerus and collar-
bone (clavicula) and on the other side connected by
strong muscles with the chest and spine.
At the upper part of the shoulder blade there is
an incision, the suprascapular notch, covered by a
suprascapular ligament (Fig. 1). This is the place of
entrance of the suprascapular nerve which origi-
nates from the brachial plexus (C5, C6 and some-
times C4) [1]. This nerve carries motor fibres for the
supra- and infra-scapular muscles, but sends senso-
ry branches to both the glenohumeral and acromio-
clavicular joint. It does not innervate the skin. The
suprascapular nerve divides and part of it enters the
infrascapular fossa and goes to the shoulder joint.
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How to make the diagnosis?
Patients usually complain of uni-, or occasion-
ally bilateral shoulder pain. The pain is typically
resistant to classic analgesia although some drugs
may be helpful for some time (see therapy). Pa-
tient lying on one side may complain of sleep-
lessness with nocturnal pain. Overhead move-
ments may be extremely painful and the patient
may avoid these. The Thompson and Kopell test
is helpful but not discriminative. Pain on pres-
sure with the index finger on the suprascapular
fossa will add to the diagnosis. Disproportionate
atrophy of the supra- and infraspinatus muscles
(uni- or bilaterally) is very suggestive for SSNE [9,
10]. Winging of the scapula (scapula alata) may
Table 1. Situations where SSNE can be expected
and/or anticipated in palliative care
Weakness and cachexia




Patients lying on one side (with lung, pleura or liver
pathology) by default
Dyspnoeic patients using their accessory muscles to
ease breathing
The anatomy of the suprascapular notch has individ-
ual variance, from wide and open to narrow and hole-
like [2]. It is here where the nerve can become entrapped
and inflamed producing irritation and pain. The other
place when similar reaction can take place is the narrow
space between the supra- and infra-scapular fossa. This
second situation is of less importance to palliative care
and we shall leave it out of the scope of this article.
Mechanism of suprascapular nerve
entrapment (SSNE)
Shoulder movement can increase or decrease
traction on the suprascapular nerve. The maximal
traction is generated when you ask the patient to
reach, with his arm (his elbow at the level of his
eyes) to the contralateral scapula (Fig. 2). This is
called Thompson and Kopell test. The patient with
SSNE will experience pain in his shoulder.
Repeated traction of the nerve can occur during
overhead training (e.g. baseball, volleyball, basket-
ball or athletics) [3, 4]. Accidental lesions like scapu-
la fracture are known reasons of suprascapular nerve
dysfunction and neuropathy [5]. Repeated move-
ments with shoulders (assembly lines) put the work-
ers at risk of SSNE.
In palliative care there is a different mechanism
probably more important [6]. Due to weak rotatory
cuff muscles, winging of the scapula increases caus-
ing repeated traction of the suprascapular nerve.
This is especially the case when the patient over-
loads their shoulders. See Table 1.
Tumour growth, both malignant and benign, that
directly compresses the suprascapular nerve is sel-
dom encountered [7, 8].
Figure 2. Thompson and Kopell test. Ask patient to
reach with his arm to the contralateral shoulderblade
Figure 1. Suprascapular nerve originates in brachial
plexus
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also be evident. In some cases, diagnosis is diffi-
cult but can be confirmed by resolution follow-
ing treatment.
Treatment
As previously mentioned, systemic analgesics are
often ineffective, especially when the measures to
relieve the burden are not undertaken. The nature
of the nerve entrapment is usually inflammatory and
maximal in the suprascapular notch; anti-inflamma-
tory drugs may help initially, but can mask the pain
and delay diagnosis. The most important aspect of
treatment is prevention of recurrence. This may in-
volve special equipment like electric wheelchairs,
hoists and slings) and teaching patients how to use
them.
In some patients, usually not the terminally ill,
with specific anatomic variants, surgical treatment
may be appropriate. Nerve decompression is effec-
tive in most of these patients [11].
Local treatment is by a nerve blockade. This
may be performed by a skilled anaesthesiologist
using neurodestructive measures, e.g. 10% phe-
nol, but more often patients would be seen at
the bedside by the non-anaesthesiologist for in-
filtration with several millilitres of bupivacaine
(0.5%) and corticosteroids, e.g. methylpredniso-
lone [12]. In most patients this treatment is suffi-
cient and the pain may remain controlled for as
long as 23 months. Injecting the latter drug com-
bination one should think about the bi-phasic
effect. At first bupivacaine would act as a local
anaesthetic and the pain can be relieved within
2030 minutes lasting for 1224 hours. A good
response in the first 30 minutes gives indicateon
of correct placement/diagnosis. Depo-corticoster-
oids may need some time to diffuse to the right
place and the onset of the effect may be delayed
for 23 days. So there may be a gap and after
initial good analgesia the pain may reappear and
disappear later again. Repeated injections are sel-
dom needed but possible. After two or three in-
jections, every 23 months corticosteroids may
induce marked atrophy. Thus after second proce-
dure neurodestructive blockade might be more
reasonable choice.
Allow the patient to sit straight up. Never do
the injection with the patient lying flat in bed.
As the Depo-medrone sediments from bupiv-
acaine you should keep the syringe up, in the
way the heavier Depo-medrone will be injected
first. Do not perform injection in patients with
lymphoedema.
The technique is simple (Fig. 3). Mark with your
nail the point of maximal pain. Localise with your
non dominant hand the bony crista. Try to intro-
duce the needle to touch the Crista fist. Move the
needle in the presumable direction of suprascapular
notch walking with the needle 23 mm at a time.
Do not allow the needle to go into the canal. The
patient may help identifying the moment of in-
creased pain. Always aspirate to check for punctur-
ing of the blood vessel. Inject slowly changing from
time to time position of the needle.
The treatment has its own limitations and ad-
verse effects. Do not try to enter with the needle in
the suprascapular canal as there is a real chance of
damage to the nerve or significant haematoma. In-
jection with a long needle, deep in the tissues has a
potential of pneumothorax. In difficult cases SSN
blockade can be performed under CT control. This is
sometimes needed with different anatomical vari-
ants [13, 14].
Another consideration is the placement of a fine
bore catheter in the region of the suprascapular
nerve, infusing local anaesthetics. This may be use-
ful in the treatment of an inoperable fracture of the
upper humerus [15] in the dying patient.
Figure 3. Technique of infiltration of the suprascapu-
lar notch with bupivacaine and depo-corticosteroids
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Conclusion
SSNE may be the reason for some if not many
shoulder pains in the terminally ill. However the
epidemiology of this phenomenon is still unknown.
Lack of awareness may cause underdiagnosis. The
symptoms of pain on compression of suprascapu-
lar notch, pain on adduction of the arm and un-
balanced atrophy of the supraspinatus muscle may
help to make the diagnosis. Many risk factors fre-
quently encountered in the terminally ill may be
identified. The treatment can be done at the bed-
side by a skilled doctor using the techniques de-
scribed. It is not dangerous and only a few minor
complications are known. We hope that this arti-
cle will contribute to increased awareness about
this syndrome amongst the professionals in pal-
liative care.
References
1. Yan J, Wu H, Aizawa Y, Horiguchi M. The human supras-
capular nerve belongs to both anterior and posterior
divisions of the brachial plexus. Okajimas Folia Anat Jpn
1999; 76: 149155.
2. Rengachary SS, Burr D, Lucas S, Hassanein KM, Mohn
MP, Matzke H. Suprascapular entrapment neuropathy: a
clinical, anatomical, and comparative study. Part 2: ana-
tomical study. Neurosurgery 1979; 5: 447451.
3. Dramis A, Pimpalnerkar A. Suprascapular neuropathy in
volleyball players. Acta Orthop Belg 2005; 71: 269272.
4. Safran MR. Nerve injury about the shoulder in athletes,
part 1: suprascapular nerve and axillary nerve. Am J Sports
Med 2004; 32: 803819.
5. Weaver HL. Isolated suprascapular nerve lesions. Injury
1983; 15: 117126.
6. flylicz Z, Haajman J. Suprascapular nerve entrapment: a
neglected cause of shoulder pain in cachectic patients? J
Pain Symptom Manage 2000; 20: 315317.
7. Hazrati Y, Miller S, Moore S, Hausman M, Flatow E. Su-
prascapular nerve entrapment secondary to a lipoma.
Clin Orthop 2003; 124128.
8. Faridah Y, Abdullah BJ. Non-Hodgkins lymphoma with
left suprascapular neuropathy on magnetic resonance
imaging. Hong Kong Med J 2003; 9: 134136.
9. Steiman I. Painless infraspinatus atrophy due to suprascapular
nerve entrapment. Arch Phys Med Rehabil 1988; 69: 641643.
10. Zehetgruber H, Noske H, Lang T, Wurnig C. Suprascapular nerve
entrapment. A meta-analysis. Int Orthop 2002; 26: 339343.
11. Post M. Diagnosis and treatment of suprascapular nerve
entrapment. Clin Orthop 1999; 92100.
12. Shanahan EM, Ahern M, Smith M, Wetherall M, Bresni-
han B, FitzGerald O. Suprascapular nerve block (using
bupivacaine and methylprednisolone acetate) in chronic
shoulder pain. Ann Rheum Dis 2003; 62: 400406.
13. Shanahan EM, Smith MD, Wetherall M, Lott CW,
Slavotinek J, FitzGerald O et al. Suprascapular nerve block
in chronic shoulder pain: are the radiologists better? Ann
Rheum Dis 2004; 63: 10351040.
14. Schneider-Kolsky ME, Pike J, Connell DA. CT-guided su-
prascapular nerve blocks: a pilot study. Skeletal Radiol
2004; 33: 277282.
15. Coetzee GJ, de Beer JF, Pritchard MG, van Rooyen K.
Suprascapular nerve block: an alternative method of plac-
ing a catheter for continuous nerve block. Reg Anesth
Pain Med 2004; 29: 7576.
